Trademarkia Logo

Canada

C$
NEXRETYS
REGISTERED

on 4 Jan 2023

Last Applicant/ Owned by

EVIVE BIOTECHNOLOGY (SHANGHAI) LTD.

Floor 3, Building 1,No. 400 Fangchun Road,China (Shanghai) Pilot Free Trade Zone201207 Shanghai

CN

Serial Number

2067934 filed on 24th Sept 2020

Registration Number

TMA1159241 registered on 4th Jan 2023

Registration expiry Date

24th Sept 2030

Correspondent Address

ANITA MAR

dba Trademark AngelSuite 521,6-2557 Dougall Avenue,Windsor,

ONTARIO

CA

N8X1T5

NEXRETYS

Trademark usage description

chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammator Read More

Classification Information


Class [005]
Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; human medicines for the treatment or prevention of inflammatory disease, graft-versushost disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; biochemical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; pharmaceutical preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medicinal capsules for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical biological preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical ointments, namely, medicated ointments for treating or preventing inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; diagnostic reagents for medical purposes; diagnostic reagents for veterinary purposes


Classification kind code

11

Mark Details


Serial Number

2067934

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 28th Mar 2022
Search Recorded
Submitted for opposition 20
on 28th Mar 2022
Examiner's First Report
Submitted for opposition 223
on 28th Mar 2022
Total Provisional Refusal
Submitted for opposition 135
on 24th Nov 2021
Amendment to Application
Submitted for opposition 256
on 4th Oct 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 3rd Dec 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Dec 2020
Created
Submitted for opposition 31
on 2th Dec 2020
Formalized
Submitted for opposition 30
on 24th Sept 2020
Filed
Submitted for opposition 228
on 24th Sept 2020
International Registration